Limitations of glycosylated haemoglobin as an index of glucose intolerance

Diabetes Research and Clinical Practice

Volumn 47, Issue 2, 2000, Pages 129-133

  Snehalatha, C ^a   Ramachandran, A ^a   Satyavani, K ^a   Vijay, V ^a  

^a Diabetes Research Centre Tamil Nadu   (India)

Author keywords

Diagnostic criterion; Glucose intolerance; Glycated haemoglobin; HbA(1c)

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST;

ADULT; AUTOANALYSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; MALE; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS;

EID: 0033988467     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00109-6     Document Type: Article

References (16)

1. Goldstein D., Little R., Wiedmeyer H., England J., Mckenzie E. Glycated hemoglobin: methodologies and clinical applications. Clin. Chem. 32(Suppl.):1986;B64-B70.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
3. Tight blood pressure control and risk of macro vascular and micro vascular complications in type 2 diabetes - UKPDS 38. BMJ. 17:1998;703-712.
4. Yudkin J.S., Forrest R.D., Jackson C.A., Ryle A.J., Davie S., Gould B.J. Unexplained variability of glycated hemoglobin in non-diabetic subjects not related to glycemia. Diabetologia. 33:1990;208-215.
5. 1 levels in normal glucose tolerance. Diabetes Care. 11:1988;422-428.
6. Kilpatrick E.S., Maylor P.W., Keevil B.G. Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care. 21:1998;261-264.
7. Bouma M., Kriegsman D.M., Dekker J.H. et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin using patients with type 2 diabetes? Diabetes Care. 22:1999;904-907.
8. Eross J., Kreutzmann D., Jimenez M. et al. Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma and dried blood. Ann. Clin. Biochem. 21:1984;477.
9. 1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care. 21:1998;1221-1225.
10. 1c, and fructosamine on diabetes screening. Diabetes Care. 11:1991;1075-1077.
11. Alberti K.G.M.M., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 15:1998;539-553. for the WHO consultation.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
13. Sosenko J.M., Fluckiger R., Platt O.S., Gabbay K.H. Glycosylation of variant hemoglobin in normal and diabetic subjects. Diabetes Care. 3:1980;590-593.
14. Phillipou G., Phillips P.J. Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin. Chem. 39:1993;2305-2308.
15. Gilbert R.E., Young V., Goodali I., Jerums G. Interlaboratory variation of GHb assays in Victoria, Australia. Diabetes Care. 19:1996;730-734.
16. Peters A.L., Davidson M.B., Schringer D.L., Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. JAMA. 276:1996;1246-1252.